Log In
BCIQ
Print this Print this
 

EPO-018

  Manage Alerts
Collapse Summary General Information
Company Jiangsu Hansoh Pharmaceutical Co. Ltd.
DescriptionPegol-Sihematide
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today